Annual EBITDA:
$9.21M+$9.40M(+4847.42%)Summary
- As of today, NAGE annual EBITDA is $9.21 million, with the most recent change of +$9.40 million (+4847.42%) on December 31, 2024.
- During the last 3 years, NAGE annual EBITDA has risen by +$18.26 million (+201.80%).
- NAGE annual EBITDA is now at all-time high.
Performance
NAGE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$4.43M+$1.05M(+31.06%)Summary
- As of today, NAGE quarterly EBITDA is $4.43 million, with the most recent change of +$1.05 million (+31.06%) on September 30, 2025.
- Over the past year, NAGE quarterly EBITDA has increased by +$1.26 million (+39.87%).
- NAGE quarterly EBITDA is now -40.67% below its all-time high of $7.47 million, reached on December 31, 2024.
Performance
NAGE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$20.25M+$1.26M(+6.65%)Summary
- As of today, NAGE TTM EBITDA is $20.25 million, with the most recent change of +$1.26 million (+6.65%) on September 30, 2025.
- Over the past year, NAGE TTM EBITDA has increased by +$15.10 million (+293.47%).
- NAGE TTM EBITDA is now at all-time high.
Performance
NAGE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NAGE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +4847.4% | +39.9% | +293.5% |
| 3Y3 Years | +201.8% | +148.4% | +311.9% |
| 5Y5 Years | +149.8% | +222.4% | +216.0% |
NAGE EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +201.8% | -40.7% | +350.1% | at high | +311.9% |
| 5Y | 5-Year | at high | +149.8% | -40.7% | +154.5% | at high | +204.0% |
| All-Time | All-Time | at high | +128.5% | -40.7% | +151.5% | at high | +161.5% |
NAGE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $4.43M(+31.1%) | $20.25M(+6.7%) |
| Jun 2025 | - | $3.38M(-31.9%) | $18.98M(+14.2%) |
| Mar 2025 | - | $4.97M(-33.5%) | $16.62M(+38.4%) |
| Dec 2024 | $9.21M(+4847.4%) | $7.47M(+135.8%) | $12.01M(+133.4%) |
| Sep 2024 | - | $3.17M(+212.4%) | $5.15M(+225.9%) |
| Jun 2024 | - | $1.01M(+182.5%) | $1.58M(+230.8%) |
| Mar 2024 | - | $359.00K(-40.7%) | -$1.21M(+24.3%) |
| Dec 2023 | -$194.00K(+97.2%) | - | - |
| Dec 2023 | - | $605.00K(+251.6%) | -$1.59M(+42.8%) |
| Sep 2023 | - | -$399.00K(+77.5%) | -$2.79M(-360.8%) |
| Jun 2023 | - | -$1.77M(-6228.6%) | -$605.00K(+74.7%) |
| Mar 2023 | - | -$28.00K(+95.2%) | -$2.39M(+65.1%) |
| Dec 2022 | -$6.84M(+24.4%) | -$589.00K(-133.0%) | -$6.84M(+28.4%) |
| Sep 2022 | - | $1.78M(+150.2%) | -$9.56M(+50.9%) |
| Jun 2022 | - | -$3.56M(+20.7%) | -$19.47M(-15.5%) |
| Mar 2022 | - | -$4.48M(-35.8%) | -$16.85M(-17.7%) |
| Dec 2021 | -$9.05M(+7.1%) | -$3.30M(+59.4%) | -$14.32M(-49.1%) |
| Sep 2021 | - | -$8.13M(-765.3%) | -$9.61M(-88.4%) |
| Jun 2021 | - | -$939.00K(+52.0%) | -$5.10M(+28.9%) |
| Mar 2021 | - | -$1.96M(-238.3%) | -$7.17M(+26.4%) |
| Dec 2020 | -$9.74M(+47.3%) | $1.41M(+139.1%) | -$9.74M(+44.2%) |
| Sep 2020 | - | -$3.62M(-20.1%) | -$17.46M(+14.1%) |
| Jun 2020 | - | -$3.01M(+33.3%) | -$20.32M(+15.7%) |
| Mar 2020 | - | -$4.52M(+28.3%) | -$24.10M(+12.6%) |
| Dec 2019 | -$18.48M(+42.8%) | -$6.30M(+2.8%) | -$27.58M(+5.8%) |
| Sep 2019 | - | -$6.49M(+4.4%) | -$29.28M(+6.0%) |
| Jun 2019 | - | -$6.79M(+15.2%) | -$31.16M(+2.9%) |
| Mar 2019 | - | -$8.00M(+0.1%) | -$32.11M(+0.7%) |
| Dec 2018 | -$32.33M(-106.4%) | -$8.01M(+4.3%) | -$32.33M(+1.8%) |
| Sep 2018 | - | -$8.37M(-8.2%) | -$32.93M(-19.5%) |
| Jun 2018 | - | -$7.73M(+5.9%) | -$27.55M(-23.7%) |
| Mar 2018 | - | -$8.22M(+4.5%) | -$22.26M(-42.1%) |
| Dec 2017 | -$15.66M(-530.1%) | -$8.61M(-188.1%) | -$15.66M(-72.0%) |
| Sep 2017 | - | -$2.99M(-22.0%) | -$9.11M(-31.1%) |
| Jun 2017 | - | -$2.45M(-51.2%) | -$6.94M(-76.7%) |
| Mar 2017 | - | -$1.62M(+21.0%) | -$3.93M(-123.0%) |
| Dec 2016 | -$2.49M | -$2.05M(-148.6%) | -$1.76M(-6650.2%) |
| Sep 2016 | - | -$824.40K(-246.1%) | $26.90K(-97.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $564.10K(+3.0%) | $1.11M(+149.9%) |
| Mar 2016 | - | $547.90K(+310.2%) | $445.20K(+147.8%) |
| Dec 2015 | -$1.82M(+62.0%) | -$260.70K(-199.8%) | -$931.70K(+44.5%) |
| Sep 2015 | - | $261.30K(+353.0%) | -$1.68M(+33.5%) |
| Jun 2015 | - | -$103.30K(+87.5%) | -$2.52M(+34.8%) |
| Mar 2015 | - | -$829.00K(+17.7%) | -$3.87M(+19.4%) |
| Dec 2014 | -$4.80M(-12.0%) | -$1.01M(-72.7%) | -$4.80M(-8.3%) |
| Sep 2014 | - | -$583.40K(+59.8%) | -$4.43M(+10.1%) |
| Jun 2014 | - | -$1.45M(+17.4%) | -$4.93M(-11.3%) |
| Mar 2014 | - | -$1.76M(-175.6%) | -$4.43M(-10.7%) |
| Dec 2013 | -$4.29M(+59.6%) | -$638.20K(+40.9%) | -$4.00M(+19.5%) |
| Sep 2013 | - | -$1.08M(-13.5%) | -$4.97M(+6.9%) |
| Jun 2013 | - | -$952.30K(+28.5%) | -$5.34M(+35.6%) |
| Mar 2013 | - | -$1.33M(+17.1%) | -$8.29M(+26.6%) |
| Dec 2012 | -$10.62M(-42.3%) | -$1.61M(-11.1%) | -$11.29M(+6.5%) |
| Sep 2012 | - | -$1.45M(+62.9%) | -$12.07M(+6.6%) |
| Jun 2012 | - | -$3.90M(+10.0%) | -$12.92M(-20.2%) |
| Mar 2012 | - | -$4.34M(-81.6%) | -$10.75M(-44.0%) |
| Dec 2011 | -$7.47M(-358.1%) | -$2.39M(-3.9%) | -$7.47M(-25.5%) |
| Sep 2011 | - | -$2.30M(-32.6%) | -$5.95M(-34.4%) |
| Jun 2011 | - | -$1.73M(-65.4%) | -$4.43M(-53.1%) |
| Mar 2011 | - | -$1.05M(-20.3%) | -$2.89M(-68.9%) |
| Dec 2010 | -$1.63M(-227.1%) | -$871.00K(-12.5%) | -$1.71M(-705.4%) |
| Sep 2010 | - | -$774.20K(-292.4%) | -$212.40K(-143.8%) |
| Jun 2010 | - | -$197.30K(-249.7%) | $485.20K(-2.0%) |
| Mar 2010 | - | $131.80K(-79.0%) | $494.90K(+249.0%) |
| Dec 2009 | -$498.20K(+70.6%) | $627.30K(+918.9%) | $141.80K(+112.6%) |
| Sep 2009 | - | -$76.60K(+59.2%) | -$1.13M(+31.9%) |
| Jun 2009 | - | -$187.60K(+15.2%) | -$1.65M(+13.5%) |
| Mar 2009 | - | -$221.30K(+65.4%) | -$1.91M(-12.9%) |
| Dec 2008 | -$1.69M(-4305.7%) | -$639.60K(-6.0%) | -$1.69M(-60.3%) |
| Sep 2008 | - | -$603.40K(-35.4%) | -$1.06M(-131.2%) |
| Jun 2008 | - | -$445.80K(>-9900.0%) | -$456.50K(-3256.6%) |
| Feb 2008 | - | -$2900.00(+17.1%) | -$13.60K(+64.5%) |
| Nov 2007 | -$38.40K | -$3500.00(+18.6%) | -$38.30K(-10.1%) |
| Aug 2007 | - | -$4300.00(-48.3%) | -$34.80K(-14.1%) |
| May 2007 | - | -$2900.00(+89.5%) | -$30.50K(-10.5%) |
| Feb 2007 | - | -$27.60K | -$27.60K |
FAQ
- What is Niagen Bioscience, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. annual EBITDA year-on-year change?
- What is Niagen Bioscience, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. quarterly EBITDA year-on-year change?
- What is Niagen Bioscience, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. TTM EBITDA year-on-year change?
What is Niagen Bioscience, Inc. annual EBITDA?
The current annual EBITDA of NAGE is $9.21M
What is the all-time high annual EBITDA for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high annual EBITDA is $9.21M
What is Niagen Bioscience, Inc. annual EBITDA year-on-year change?
Over the past year, NAGE annual EBITDA has changed by +$9.40M (+4847.42%)
What is Niagen Bioscience, Inc. quarterly EBITDA?
The current quarterly EBITDA of NAGE is $4.43M
What is the all-time high quarterly EBITDA for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high quarterly EBITDA is $7.47M
What is Niagen Bioscience, Inc. quarterly EBITDA year-on-year change?
Over the past year, NAGE quarterly EBITDA has changed by +$1.26M (+39.87%)
What is Niagen Bioscience, Inc. TTM EBITDA?
The current TTM EBITDA of NAGE is $20.25M
What is the all-time high TTM EBITDA for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high TTM EBITDA is $20.25M
What is Niagen Bioscience, Inc. TTM EBITDA year-on-year change?
Over the past year, NAGE TTM EBITDA has changed by +$15.10M (+293.47%)